Research Insights
Canadian-Led HBOT Research: What the Literature Shows
244 of 14,529 indexed studies (1.7%) are led by Canadian researchers or institutions.
244
Canadian-led studies
1.7%
of the indexed corpus
This reflects research production, not clinical endorsement. Canadian-led status is determined by the country of affiliation of a study's first or last author. The presence (or absence) of Canadian-authored studies on a topic does not indicate that HBOT is approved, funded, or recommended for that use in Canada. For what is covered, see the conditions and coverage pages.
Canadian-led studies indexed per year, 2010-2025
2010
8 / 310
2011
11 / 347
2012
3 / 352
2013
13 / 373
2014
7 / 375
2015
9 / 426
2016
12 / 431
2017
6 / 387
2018
10 / 428
2019
11 / 428
2020
10 / 467
2021
10 / 491
2022
12 / 434
2023
10 / 453
2024
16 / 521
2025
11 / 631
Each row: Canadian-led studies / all indexed studies that year.
Data generated June 27, 2026; updated weekly. How this data is produced.